BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 24075432)

  • 1. Treatment of persistent corneal epithelial defect with overnight wear of a prosthetic device for the ocular surface.
    Lim P; Ridges R; Jacobs DS; Rosenthal P
    Am J Ophthalmol; 2013 Dec; 156(6):1095-101. PubMed ID: 24075432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PROSE therapy used to minimize corneal trauma in patients with corneal epithelial defects.
    Ling JD; Gire A; Pflugfelder SC
    Am J Ophthalmol; 2013 Apr; 155(4):615-619, 619.e1-2. PubMed ID: 23218704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case Series: Overnight Wear of Scleral Lens for Persistent Epithelial Defects.
    He X; Donaldson KE; Perez VL; Sotomayor P
    Optom Vis Sci; 2018 Jan; 95(1):70-75. PubMed ID: 29252903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Refractory Persistent Corneal Epithelial Defects: A Standardized Approach Using Continuous Wear PROSE Therapy.
    Ciralsky JB; Chapman KO; Rosenblatt MI; Sood P; Fernandez AG; Lee MN; Sippel KC
    Ocul Immunol Inflamm; 2015 Jun; 23(3):219-24. PubMed ID: 24654929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of persistent corneal epithelial defect with extended wear of a fluid-ventilated gas-permeable scleral contact lens.
    Rosenthal P; Cotter JM; Baum J
    Am J Ophthalmol; 2000 Jul; 130(1):33-41. PubMed ID: 11004257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prosthetic Replacement of the Ocular Surface Ecosystem (PROSE) scleral device compared to keratoplasty for the treatment of corneal ectasia.
    DeLoss KS; Fatteh NH; Hood CT
    Am J Ophthalmol; 2014 Nov; 158(5):974-82. PubMed ID: 25058902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case series: Extended wear of rigid gas permeable scleral contact lenses for the treatment of persistent corneal epithelial defects.
    Khan M; Manuel K; Vegas B; Yadav S; Hemmati R; Al-Mohtaseb Z
    Cont Lens Anterior Eye; 2019 Feb; 42(1):117-122. PubMed ID: 30266562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PROSE Treatment in Atypical Ocular Graft-Versus-Host Disease.
    Chiu GB; Theophanous C; Irvine JA
    Optom Vis Sci; 2016 Nov; 93(11):1444-1448. PubMed ID: 27741087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prosthetic replacement of the ocular surface ecosystem as treatment for ocular surface disease in patients with a history of Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Papakostas TD; Le HG; Chodosh J; Jacobs DS
    Ophthalmology; 2015 Feb; 122(2):248-53. PubMed ID: 25282251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scleral lenses in the management of ocular surface disease.
    Schornack MM; Pyle J; Patel SV
    Ophthalmology; 2014 Jul; 121(7):1398-405. PubMed ID: 24630687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of vascularized limbal keratitis with prosthetic replacement of the ocular surface system.
    Cressey A; Jacobs DS; Carrasquillo KG
    Eye Contact Lens; 2012 Mar; 38(2):137-40. PubMed ID: 22327201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Autologous serum for otherwise therapy resistant corneal epithelial defects - Prospective report on the first 70 eyes].
    Ferreira de Souza R; Kruse FE; Seitz B
    Klin Monbl Augenheilkd; 2001 Nov; 218(11):720-6. PubMed ID: 11731899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scleral contact lenses in the management of pellucid marginal degeneration.
    Rathi VM; Dumpati S; Mandathara PS; Taneja MM; Sangwan VS
    Cont Lens Anterior Eye; 2016 Jun; 39(3):217-20. PubMed ID: 26669275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcome of using Prosthetic Replacement of Ocular Surface Ecosystem (PROSE) as a drug delivery system for bevacizumab in the treatment of corneal neovascularization.
    Yin J; Jacobs DS
    Ocul Surf; 2019 Jan; 17(1):134-141. PubMed ID: 30468876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe limbal stem cell deficiency from contact lens wear: patient clinical features.
    Chan CC; Holland EJ
    Am J Ophthalmol; 2013 Mar; 155(3):544-549.e2. PubMed ID: 23218703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prosthetic Replacement of the Ocular Surface Ecosystem Scleral Lens Therapy for Exposure Keratopathy.
    Chahal JS; Heur M; Chiu GB
    Eye Contact Lens; 2017 Jul; 43(4):240-244. PubMed ID: 27171131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PROSE treatment of corneal ectasia.
    Baran I; Bradley JA; Alipour F; Rosenthal P; Le HG; Jacobs DS
    Cont Lens Anterior Eye; 2012 Oct; 35(5):222-7. PubMed ID: 22633003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of the Boston Ocular Surface Prosthesis in the management of severe periorbital thermal injuries: a case series of 10 patients.
    Kalwerisky K; Davies B; Mihora L; Czyz CN; Foster JA; DeMartelaere S
    Ophthalmology; 2012 Mar; 119(3):516-21. PubMed ID: 22133791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of bandage contact lens application in corneal epithelialization and pain alleviation following corneal transplantation; prospective, randomized clinical trial.
    Shimazaki J; Shigeyasu C; Saijo-Ban Y; Dogru M; Den S
    BMC Ophthalmol; 2016 Oct; 16(1):174. PubMed ID: 27716123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bandage contact lens and topical indomethacin for treating persistent corneal epithelial defects after vitreoretinal surgery.
    Oskouee SJ; Amuzadeh J; Rajabi MT
    Cornea; 2007 Dec; 26(10):1178-81. PubMed ID: 18043171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.